Anebulo Pharmaceuticals (ANEB) Earnings Date & Reports

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANEB is expected to report earnings to fall 11.11% to -7 cents per share on May 08

Anebulo Pharmaceuticals ANEB Stock Earnings Reports

Q1'25

Est.

$-0.08

Q4'24

Missed

by $0.01

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.06

Q1'24

Beat

by $0.06

The last earnings report on February 14 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 12.51K shares outstanding, the current market capitalization sits at 44.37M.

View a ticker or compare two or three

Compare

ANEB